{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:26:07Z","timestamp":1780680367202,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.suronc.2026.102448","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:26:53Z","timestamp":1778758013000},"page":"102448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Conversion surgery for perihilar cholangiocarcinoma after immune checkpoint inhibitor\u2013combined chemotherapy with the biliary stent\u2013based strategy"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9803-1339","authenticated-orcid":false,"given":"Takeshi","family":"Kano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saburo","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nunokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morito","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Matsudaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riki","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taizen","family":"Urahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suronc.2026.102448_bib1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/gutjnl-2011-301748","article-title":"Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update","volume":"61","author":"Khan","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.suronc.2026.102448_bib2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.suronc.2026.102448_bib3","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S2468-1253(24)00095-5","article-title":"Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study","volume":"9","author":"Oh","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.suronc.2026.102448_bib4","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.suronc.2026.102448_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.6004\/jnccn.2025.0042","article-title":"Biliary tract cancers, version 2.2025, NCCN clinical practice guidelines in oncology","volume":"23","author":"Benson","year":"2025","journal-title":"J. Natl. Compr. Cancer Netw. : J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.suronc.2026.102448_bib6","first-page":"170","article-title":"Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver","volume":"140","author":"Bismuth","year":"1975","journal-title":"Surg. Gynecol. Obstet."},{"key":"10.1016\/j.suronc.2026.102448_bib7","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0","author":"National","year":"2017"},{"key":"10.1016\/j.suronc.2026.102448_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The clavien-dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2026.102448_bib9","series-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2017"},{"key":"10.1016\/j.suronc.2026.102448_bib10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archsurg.1992.01420110083017","article-title":"Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas","volume":"127","author":"Evans","year":"1992","journal-title":"Arch. Surg."},{"key":"10.1016\/j.suronc.2026.102448_bib11","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/00031348251339534","article-title":"Successful conversion surgery in advanced hilar cholangiocarcinoma treated with durvalumab plus gemcitabine and cisplatin","volume":"91","author":"Kiuchi","year":"2025","journal-title":"Am. Surg."},{"key":"10.1016\/j.suronc.2026.102448_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70183-y","article-title":"Comparison of double-layer large-diameter and conventional small-diameter plastic stents for preoperative biliary drainage in resectable distal malignant biliary obstruction","volume":"10","author":"Matsubara","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.suronc.2026.102448_bib14","doi-asserted-by":"crossref","DOI":"10.70352\/scrj.cr.25-0025","article-title":"Pathological complete response after pembrolizumab treatment for unresectable perihilar cholangiocarcinoma with high microsatellite instability: a case report","volume":"11","author":"Inokawa","year":"2025","journal-title":"Surg Case Rep"},{"key":"10.1016\/j.suronc.2026.102448_bib15","first-page":"254","article-title":"Durvalumab-combined chemotherapy for biliary tract cancer in a Japanese expert center: initial 50 cases in daily practice","volume":"87","author":"Inokawa","year":"2025","journal-title":"Nagoya J. Med. Sci."},{"key":"10.1016\/j.suronc.2026.102448_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17243971","article-title":"Gemcitabine + cisplatin + S-1 treatment for advanced cholangiocarcinoma: cost-effective, with better progression-free survival versus standard treatment with gemcitabine + cisplatin + durvalumab","volume":"17","author":"Morita","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.suronc.2026.102448_bib17","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.21873\/invivo.13974","article-title":"Conversion surgery performed following durvalumab combined with gemcitabine and cisplatin in cholangiocarcinoma: a case report","volume":"39","author":"Tagayasu","year":"2025","journal-title":"In Vivo"},{"key":"10.1016\/j.suronc.2026.102448_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108733","article-title":"Feasibility of major hepatectomy following preoperative chemotherapy for advanced perihilar cholangiocarcinoma","volume":"51","author":"Takahashi","year":"2025","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2026.102448_bib19","doi-asserted-by":"crossref","DOI":"10.70352\/scrj.cr.25-0555","article-title":"Conversion surgery after complete response to immune checkpoint inhibitor-based sequential chemotherapy for initially unresectable perihilar cholangiocarcinoma: a case report","volume":"11","author":"Tomino","year":"2025","journal-title":"Surg Case Rep"},{"key":"10.1016\/j.suronc.2026.102448_bib20","doi-asserted-by":"crossref","DOI":"10.70352\/scrj.cr.25-0023","article-title":"Hilar cholangiocarcinoma with para-aortic lymph node metastasis treated with chemoimmunotherapy and conversion surgery: a case report","volume":"11","author":"Yasui","year":"2025","journal-title":"Surg Case Rep"}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096074042600099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096074042600099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:03:49Z","timestamp":1780664629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096074042600099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":19,"alternative-id":["S096074042600099X"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102448","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conversion surgery for perihilar cholangiocarcinoma after immune checkpoint inhibitor\u2013combined chemotherapy with the biliary stent\u2013based strategy","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102448"}}